Skip to content
Events

    • Details

    Hear from Steve Barnard about the latest Illumina innovations from library prep, sequencing, and analysis and learn how we are enabling transformative applications using multiomics. Niall Lennon, PhD from the Broad Institute of MIT will join Steve to provide insights into new Illumina technology.
    Steve Barnard, PhD

    Steve Barnard, PhD
    Chief Technology Officer
    Illumina

    Steve Barnard, PhD

    Niall Lennon, PhD
    Chair and Chief Scientific Officer
    Broad Clinical Labs, MIT

     

    M-AMR-01684
    Fill Out Form to Access Webinar

    Your email address is never shared with third parties.

    Date & Time
    6 Nov. 2024
    Topic
    Instruments, Software & informatics
    Watch Now

    Related Events

    Apr 2
    Bio-IT World Conference & Expo 2025
    Apr 2, 2025 – Apr 4, 2025
    Visit Illumina booth 704 to learn about the latest advancements in multiomics discovery.
    View Event
    Apr 9
    How Can AI and Automation Boost Cytogenetic Array Analysis Efficiencies?
    Apr 9, 2025
    Labs face increasing challenges with variant knowledge, sample volume, and evolving assay needs, all while maintaining operational and cost efficiencies. This 20-minute webinar and live demo will show how bioinformatic solutions can streamline data analysis and interpretation in array clinical research workflows.
    View Event
    May 5
    APHL 2025 Annual Conference
    May 5, 2025 – May 8, 2025
    APHL 2025 is a conference for the public health​ laboratory community, bringing together leaders, scientists, influencers and partners to share issues, trends, and best practices driving laboratory science and public health today.
    View Event
    For Research Use Only

    Not for use in diagnostic procedures (except as specifically noted).

    Innovative technologies

    At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

    All trademarks are the property of Illumina, Inc. or their respective owners.
    For specific trademark information, see sapac.illumina.com/company/legal.html.

    © 2025 Illumina, Inc. All rights reserved.